Stay updated on STX209 Effects in ASD Clinical Trial
Sign up to get notified when there's something new on the STX209 Effects in ASD Clinical Trial page.

Latest updates to the STX209 Effects in ASD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a Locations section highlighting Pennsylvania. Updated the revision to v3.3.3 and removed the HHS Vulnerability Disclosure and Pennsylvania Locations entry (v3.3.2).SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoval of the government funding status and data currency disclaimer from the page. This may affect how clearly users understand whether the trial information is current.SummaryDifference0.4%

- Check70 days agoChange DetectedNo additions or deletions affecting core content were detected. The page's study details, eligibility criteria, and primary outcomes appear unchanged.SummaryDifference0.4%

- Check91 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check99 days agoChange DetectedUpdated to v3.1.0 and removed several older related topics (including MedlinePlus Drug Safety topics and v3.0.2), indicating a cleanup and version refresh rather than adding new core content.SummaryDifference0.4%

Stay in the know with updates to STX209 Effects in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STX209 Effects in ASD Clinical Trial page.